UARK 2006-66, Total Therapy 3B: An Extension of UARK 2003-33 Total Therapy
UARK 2006-66, Total Therapy 3B: An Extension of UARK 2003-33 Total Therapy
Active, not recruiting · NCT00572169 · Registry updated 2026-02-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| UARK 2006-66, Total Therapy 3B: An Extension of UARK 2003-33 Total Therapy | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Active, not recruiting | Phase 3 | 2026-02-05 | NCT00572169 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Arkansas | 76 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Arkansas for Medical Sciences/Myeloma Institute | Little Rock | United States | 1 |